ORBIMED ADVISORS LLC Arcus Biosciences, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$7.92M
portfolio value

Arcus Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 303K shares 7.92M $26.16 303K
Q3 2020 share Decrease -100.00% -220.35K shares -5.45M $17.14 0
Q2 2020 share Increase 0.00% 220.35K shares 5.45M $24.74 220.35K